Home » Topics » BioWorld Science, Nephrology

BioWorld Science, Nephrology
RSS

FDA grants orphan drug designation to OMS-721 for IgA nephropathy

Aug. 7, 2017

Quark Pharmaceuticals reports positive results from QPI-1002 phase II study

July 28, 2017

Encouraging phase IIa results for DMX-200 in patients with proteinuria

July 14, 2017

Results from phase I trial of oral CR-845 in hemodialysis patients with CKD

July 13, 2017

Bardoxolone methyl granted U.S. orphan drug status for Alport syndrome

July 10, 2017

ADV-7103 granted E.U. orphan drug designation for distal renal tubulopathy acidosis

July 7, 2017

Human adipose-derived stromal cells effectively treat experimental glomerulonephritis

July 5, 2017

Clarus resubmits NDA for Jatenzo

June 27, 2017

Novel SSAO inhibitor UD-014 ameliorates experimental diabetic nephropathy

June 26, 2017

FDA gives breakthrough therapy designation to CR-845 from Cara Therapeutics

June 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 31, 2026.
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
AIDS 2026: New targets for metabolic dysfunction despite ART
BioWorld
Although antiretroviral therapy (ART) can suppress HIV to undetectable levels, a growing body of evidence suggests that the virus leaves a lasting biological...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
Jingxin discloses new muscarinic and sigma receptor agonists
BioWorld Science
Shanghai Jingxin Biopharmaceutical Co. Ltd. and Zhejiang Jingxin Pharmaceutical Co. Ltd. have synthesized new muscarinic acetylcholine receptor and sigma receptor...